William M. Haskel Paratek Pharmaceuticals, Inc. (PRTK) insider trading activity

William M. Haskel is CLO, General Counsel & Sec. of Paratek Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of PRTK, which is worth approximately $0. The most recent transaction as insider was on Sep 21, 2023, when has been sold 447,024 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

William M. Haskel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 21 2023	SELL Sale (or disposition) back to the issuer	-	447,024 Reduced 100.0%	0 Common Stock
Aug 09 2023	SELL Open market or private sale	$75,957 $2.2 p/Share	34,526 Reduced 7.17%	447,024 Common Stock
Aug 08 2023	BUY Grant, award, or other acquisition	-	73,750 Added 13.28%	481,550 Common Stock
Dec 21 2022	SELL Open market or private sale	$13,943 $1.99 p/Share	7,007 Reduced 1.69%	407,800 Common Stock
Dec 20 2022	BUY Grant, award, or other acquisition	-	15,000 Added 3.49%	414,807 Common Stock
Dec 13 2022	SELL Open market or private sale	$46,224 $1.96 p/Share	23,584 Reduced 5.57%	399,807 Common Stock
Dec 12 2022	SELL Open market or private sale	$28,531 $1.98 p/Share	14,410 Reduced 3.29%	423,391 Common Stock

Oct 28 2022	SELL Open market or private sale	$15,205 $3.47 p/Share	4,382 Reduced 0.99%	437,801 Common Stock
Oct 25 2022	BUY Grant, award, or other acquisition	-	9,250 Added 2.05%	442,183 Common Stock
Aug 09 2022	SELL Open market or private sale	$59,725 $2.66 p/Share	22,453 Reduced 4.93%	432,933 Common Stock
Aug 08 2022	BUY Grant, award, or other acquisition	-	47,727 Added 9.49%	455,386 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	67,500 Added 14.21%	407,659 Common Stock
Dec 15 2021	SELL Open market or private sale	$73,350 $4.27 p/Share	17,178 Reduced 4.81%	340,159 Common Stock
Dec 14 2021	SELL Open market or private sale	$36,323 $4.37 p/Share	8,312 Reduced 2.27%	357,337 Common Stock
Dec 13 2021	SELL Open market or private sale	$21,552 $4.42 p/Share	4,876 Reduced 1.32%	365,649 Common Stock
Aug 17 2021	SELL Open market or private sale	$49,623 $5.12 p/Share	9,692 Reduced 2.55%	370,525 Common Stock
Aug 16 2021	BUY Grant, award, or other acquisition	-	23,125 Added 5.73%	380,217 Common Stock
Jun 04 2021	SELL Open market or private sale	$73,342 $9.7 p/Share	7,561 Reduced 2.07%	357,092 Common Stock
May 27 2021	BUY Grant, award, or other acquisition	-	28,636 Added 7.28%	364,653 Common Stock
Mar 30 2021	BUY Grant, award, or other acquisition	-	132,750 Added 28.32%	336,017 Common Stock
Dec 14 2020	SELL Open market or private sale	$45,910 $6.71 p/Share	6,842 Reduced 3.26%	203,267 Common Stock
Dec 11 2020	SELL Open market or private sale	$33,457 $6.95 p/Share	4,814 Reduced 2.24%	210,109 Common Stock
Nov 13 2020	SELL Open market or private sale	$40,870 $5.93 p/Share	6,892 Reduced 3.11%	214,923 Common Stock
Nov 12 2020	BUY Grant, award, or other acquisition	-	23,125 Added 9.44%	221,815 Common Stock

WMH

William M. Haskel

CLO, General Counsel & Sec.

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PRTK shares.

Notify only if

Value

Insider Trading

Get notified when an Paratek Pharmaceuticals, Inc. insider buys or sells PRTK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Paratek Pharmaceuticals, Inc.

Track Activities on PRTK

Account